Unknown OBSERVATIONAL NCT02099422

Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome (TOPIC)

The Randomized TOPIC Study : Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

Sponsor: Hôpital de la Timone

Conditions Acute Coronary Syndrome Antiplatelet Therapy Coronary Stenting

Updated 6 times since 2017 Last updated: Mar 26, 2014 Started: Jan 31, 2013 Primary completion: Jan 31, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Coronary Syndrome and Antiplatelet Therapy, this trial is ongoing. The trial is conducted by Hôpital de la Timone and has accumulated 6 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hôpital de la Timone

Data source: Hôpital de la Timone

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France